retatrutide approval status FDA 2026: Everything We Know So Far Retatrutide approval: FDA status, clinical

Gastrointestinal (GI) side effects including delayed gastric emptying, gallstones, and ileus have been associated with glucagon-like peptide-1 receptor agonist (GLP-1) medications

But before she could go ahead with the stomach reduction procedure, she was introduced to Wegovy by a doctor

Clinical trials show no significant difference in outcomes between morning and evening injections

Kuraji M, Matsuno T, Satoh T (2016) Astaxanthin affects oxidative stress and hyposalivation in aging mice

Cardiovascular Benefits: GLP-1s have shown cardiovascular protective effects, reducing risk of heart attack and stroke in people with type 2 diabetes 4